— Olutasidenib continued to demonstrate durable efficacy and a manageable safety profile in a broad range of patients with R/R mIDH1 AML, including those previously treated with venetoclax-based regimens — Rigel advances its strategic collaborations to further evaluate olutasidenib with the activation of a fifth study with MD Anderson and enrollment of the first patient […]

PRA Group, Inc. (Nasdaq: PRAA) (the “Company”), a global leader in acquiring and collecting nonperforming loans, announced today that management is scheduled to participate at the following investor events: https://mma.prnewswire.com/media/819349/PRA_Logo.jpg The Citizens Financial Services ConferenceDate: Tuesday, November 18, 2025Format: 1×1 and small group meetings onlyLocation: Lotte New York Palace, New York, New YorkCompany Participants: President

Topline data readout from Phase 1a clinical trial expected in Q1 2026 Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced the completion of enrollment in the ongoing Phase 1a clinical trial of BTX-9341, a potent and selective CDK4/6 degrader, for the

First-line treatment with TREMFYA® shows significant inhibition of radiographic progression at Week 24, which was sustained through Week 48, preserving joint health with a well-established safety profile More than half of TREMFYA®-treated patients across both dose groups achieved a 50% improvement in signs and symptoms of psoriatic arthritis by Week 48 in the Phase 3b

Intelligent, scalable cooling platforms address power density challengesdriven by AI, high-performance computing, and big data demands Airsys Cooling Technologies Inc., a global leader in mission-critical cooling solutions, today announced the launch of PowerOne, an intelligent, high-efficiency cooling solution that addresses the unprecedented data center cooling demands presented by the rise in usage of AI, hyperscale,

Oregon-based Pinnacle Tax & Financial Services chooses Avantax for its tax expertise and growth resources Cetera welcomes longtime Commonwealth financial advisor Shawna Vanaken, CFP®, CPA, EA, who has joined Cetera's community of tax-focused financial professionals – Avantax. Vanaken and her team at Pinnacle Tax & Financial Services, LLC, in Beaverton, Oregon, oversee approximately $49 million

~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC)("Ensysce" or the "Company"), pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced the closing of a $4 million convertible

(NASDAQ:SILO), SARASOTA, FL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that it has selected Allucent, a global full-service clinical research organization (CRO), to support the Company's final preparations and planned submission of its investigational new drug application

(NASDAQ:RXT), SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Rackspace Technology(R) (NASDAQ: RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, today announced the appointment of Lata Varghese as Senior Vice President of Business Transformation and Phani Kishore Burre, as Senior Vice President of Services and Delivery for the Public Cloud business unit. Lata

Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment on Phase 2b/3 trial design provides a clear regulatory path for two well-controlled studies under a single protocol, strengthening the Company's position with ophthalmology-focused strategics and